Andriol Testocaps Tabooned Population: Notice for Patients with Prostate Cancer, Male breast cancer and Serious Liver Disease
As an exogenous androgen supplement, AndriolTestoapps can significantly increase testosterone levels in the body. However, such hormone interventions may accelerate the progression of specific hormone sensitive tumors and pose a severe challenge to end-stage impaired liver metabolic function. The following three types of patients are clearly prohibited from use and must be strictly avoided.
1、 Prostate cancer patients
Androgen dependent. The growth and proliferation of prostate cancer cells are highly dependent on the sustained activation of the androgen receptor signaling pathway.
Clear taboos. Supplementing with exogenous testosterone directly provides "fuel" for tumors, leading to rapid progression of local lesions and significantly increasing the risk of distant metastasis.
Clinical guidelines. The use of this medication is strictly prohibited in cases of confirmed or even highly suspected prostate cancer.
2、 Male patients with breast cancer
Hormone driven risk. Some male breast cancer also express androgen or estrogen receptor, which is sensitive to changes in sex hormone levels.
Promote deterioration. Taking testosterone undecylate capsules may disrupt hormone balance in the body or directly act on tumor receptors, stimulating malignant cell proliferation.
Usage restrictions. Those with existing or suspected male breast cancer history are absolutely contraindicated objects of the drug.
3、 Severe liver disease patients
Metabolic burden. Testosterone undecanoate needs to undergo extensive oxidative metabolism and biotransformation through the liver. Patients with severe liver diseases (such as decompensated cirrhosis and hepatocellular carcinoma) have insufficient liver cell functional reserves.
Inducing complications. Medication may induce cholestatic jaundice, liver failure, and even pose a risk of inducing liver tumors.
Check the premise. Liver function must be checked before medication, and severe damage should be avoided. Mild to moderate abnormalities should be carefully monitored to weigh the pros and cons.
Disclaimer：《Andriol Testocaps Tabooned Population: Notice for Patients with Prostate Cancer, Male breast cancer and Serious Liver Disease》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication！